Daniel A. Simkowitz - 29 Oct 2025 Form 4 Insider Report for MORGAN STANLEY (MS)

Signature
/s/ Martin M. Cohen, Attorney-in-Fact
Issuer symbol
MS
Transactions as of
29 Oct 2025
Net transactions value
$0
Form type
4
Filing time
31 Oct 2025, 16:43:22 UTC
Previous filing
18 Jul 2025
Next filing
16 Jan 2026

Quoteable Key Fact

"Daniel A. Simkowitz filed Form 4 for MORGAN STANLEY (MS) on 31 Oct 2025."

Quick Takeaways

  • This page summarizes Daniel A. Simkowitz's Form 4 filing for MORGAN STANLEY (MS).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Filing timestamp: 31 Oct 2025, 16:43.

What Changed

  • Previous filing in this sequence was filed on 18 Jul 2025.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

CIK 0001680385 Primary reporting owner

SIMKOWITZ DANIEL A

Relationship
Co-President
Address
C/O MORGAN STANLEY, 1585 BROADWAY, NEW YORK
Signature
/s/ Martin M. Cohen, Attorney-in-Fact
Signature date
31 Oct 2025

Transactions Table

MS transaction

Common Stock

Gift

Transaction value
$0
Shares
-10,000
Change %
-2.5%
Price
$0.000000
Shares after
383,757
Date
29 Oct 2025
Ownership
Direct
MS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,784
Date
29 Oct 2025
Ownership
By 401(k) Plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .